Public trial registry of the CCC-Munich

Trial AIO-PAK-0114 ALPACA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
AIO-PAK-0114 ALPACA
World
Full title
:

Induction treatment with nab-paclitaxel/gemcitabine for first-line treatment of metastatic pancreatic cancer followed by either alternating application of gemcitabine monotherapy and nab-paclitaxel/gemcitabine or continuing application of nab-paclitaxel/gemcitabine: A randomized phase II study

World
Responsible organization
:
2. Med 2. Med Ismaninger Str. 22 81675 München Germany
Indications
Classification Code Description
- Pancreas carcinoma
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy line
:
1
World
Therapy
:

Chemo - Therapieart: palliativ

Participants
Function Prename Surname Organization
World Responsible contact Hana Algül 2. Med 2. Med Ismaninger Str. 22 81675 München Germany Magnifier